Archive for February, 2014

Right Turn: Scribe this (#scio14) conference

Author: Lisa Willemse, 02/28/14

> This is the second time I have travelled down to Raleigh, North Carolina to attend the annual ScienceOnline conference. Conferences generally conjure certain standard stereotypes and expectations (i.e. lots of listening to presentations given by thought leaders standing on a stage interspersed with lots of coffee and rushed  conversations during breaks), but I can…Read more

Right Turn: Biomaterials for the 21st Century – Repairing spinal cords

Author: Stacey Johnson, 02/21/14

. Dr. Robert Langer’s enthusiasm for the limitless promise of bioengineering is infectious. With his efforts and under his tutelage, one hopes that huge advances will be made in restoring movement to the paralyzed and curing the sick through, for example, more effective drug delivery systems that can manipulate how long and where in the…Read more

Play your part: learning from the actors in clinical and translational research

Author: Guest, 02/20/14

by Paul Cassar, Stem Cell Network Scientist-in-Residence You’ve heard this already, I’m sure. Stem cell research is a multidisciplinary endeavour that requires an assemblage of scientists, engineers, clinicians, lawyers and ethicists. And I know I don’t have to tell you that to bring a new therapy to the clinic requires decades of basic, pre-clinical and…Read more

Biomimicry, bioadhesion and Dr. Jeffrey Karp: He’s a natural at what he does

Author: Roshan Yoganathan, 02/18/14

. This past weekend I was watching the Superbowl, along with millions of North Americans,not to see the Seahawks beat down the Broncos, but for all the must-see million dollar commercials. The one commercial that stood out to me was the Geico commercial with the gecko. The gecko is an interesting creature with many extraordinary…Read more

Right Turn: On (and off) the podium at the stem cell Olympics

Author: Lisa Willemse, 02/14/14

> Stem cells don’t usually feature prominently at Olympic events, unless in connection with performance enhancement, which has been alleged at both the 2008 and 2012 summer games. But, as Paul Knoepfler pointed out in his blog, if stem cell doping at the Olympic level is happening at all, it’s likely on a very small…Read more

Regenerative Medicine Deal Review: January

Author: Mark Curtis, 02/11/14

. Welcome to your Regenerative Medicine Deal Review for the month of January! There was lots of flow in January, including yet another research collaboration from Cellular Dynamics International – this time with the Nestle Institute of Health Sciences to use the company’s iCell® and MyCell® products for research into human nutrition. Aastrom entered into…Read more

Right Turn: Dance of the stem cell fairies

Author: Stacey Johnson, 02/07/14

. Science communications – #scicomm for you Twitter fans – is an important aspect of what we do here at Signals Blog and even rates its own category. Science communications aims to educate the public (and sometimes scientists) about a science-related topic. A variety of forms are used to do this, including story telling. Dance…Read more

Update from the Clinic: January

Author: Mark Curtis, 02/04/14

. Welcome to your Update from the Clinic for the month of January! We start the year off with the German health authority approving Pluristem’s next generation GMP cell manufacturing facility. Neuralstem successfully, and safely, transplants NSI-556 cells directly into the brain of its first patient in a Phase 1/2 study. Meanwhile, OncoMed and StemCells…Read more